BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8931017)

  • 1. Does monoamine oxidase inhibition by pargyline increase extracellular dopamine concentrations in the striatum?
    Blaha CD; Coury A; Phillips AG
    Neuroscience; 1996 Nov; 75(2):543-50. PubMed ID: 8931017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition.
    Wayment HK; Schenk JO; Sorg BA
    J Neurosci; 2001 Jan; 21(1):35-44. PubMed ID: 11150317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid.
    Desvignes C; Bert L; Vinet L; Denoroy L; Renaud B; Lambás-Señas L
    Neurosci Lett; 1999 Feb; 261(3):175-8. PubMed ID: 10081977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of stearate-graphite paste electrodes for chronic measurement of extracellular dopamine concentrations in the mammalian brain.
    Blaha CD
    Pharmacol Biochem Behav; 1996 Nov; 55(3):351-64. PubMed ID: 8951976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoflurane anesthesia induces biphasic effect on dopamine release in the rat striatum.
    Adachi YU; Yamada S; Satomoto M; Higuchi H; Watanabe K; Kazama T
    Brain Res Bull; 2005 Oct; 67(3):176-81. PubMed ID: 16144652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.
    Elverfors A; Pileblad E; Lagerkvist S; Bergquist F; Jonason J; Nissbrandt H
    J Neurochem; 1997 Oct; 69(4):1684-92. PubMed ID: 9326297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T; Dong B; Ishii K; Kinemuchi H
    J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid.
    Desvignes C; Bert L; Vinet L; Denoroy L; Renaud B; Lambás-Señas L
    Neurosci Lett; 1999 Apr; 264(1-3):5-8. PubMed ID: 10320000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltammetric study of extracellular dopamine near microdialysis probes acutely implanted in the striatum of the anesthetized rat.
    Borland LM; Shi G; Yang H; Michael AC
    J Neurosci Methods; 2005 Aug; 146(2):149-58. PubMed ID: 15975664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-D-aspartate antagonism.
    Mizoguchi K; Yokoo H; Yoshida M; Tanaka T; Tanaka M
    Brain Res; 1994 Oct; 662(1-2):255-8. PubMed ID: 7859080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR; Abercrombie ED
    J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdialysis with radiometric monitoring of L-[β-11C]DOPA to assess dopaminergic metabolism: effect of inhibitors of L-amino acid decarboxylase, monoamine oxidase, and catechol-O-methyltransferase on rat striatal dialysate.
    Okada M; Nakao R; Hosoi R; Zhang MR; Fukumura T; Suzuki K; Inoue O
    J Cereb Blood Flow Metab; 2011 Jan; 31(1):124-31. PubMed ID: 20407462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of transient forebrain ischemia and pargyline on extracellular concentrations of dopamine, serotonin, and their metabolites in the rat striatum as determined by in vivo microdialysis.
    Damsma G; Boisvert DP; Mudrick LA; Wenkstern D; Fibiger HC
    J Neurochem; 1990 Mar; 54(3):801-8. PubMed ID: 2303812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minor effect of tolcapone, a catechol-O-methyltransferase inhibitor, on extracellular dopamine levels modified by amphetamine or pargyline: a microdialysis study in anaesthetized rats.
    Tuomainen P; Törnwall M; Männistö PT
    Pharmacol Toxicol; 1996 Jun; 78(6):392-6. PubMed ID: 8829199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct pharmacological regulation of evoked dopamine efflux in the amygdala and striatum of the rat in vivo.
    Garris PA; Wightman RM
    Synapse; 1995 Jul; 20(3):269-79. PubMed ID: 7570359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase inhibitor-induced blockade of locomotor sensitization to quinpirole: role of striatal dopamine uptake inhibition.
    Culver KE; Rosenfeld JM; Szechtman H
    Neuropharmacology; 2002 Sep; 43(3):385-93. PubMed ID: 12243768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic analysis of ethanol effects on NMDA-evoked dopamine overflow in rat striatum.
    Lin AM; Chai CY
    Brain Res; 1995 Oct; 696(1-2):15-20. PubMed ID: 8574663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats.
    Meissner W; Harnack D; Reese R; Paul G; Reum T; Ansorge M; Kusserow H; Winter C; Morgenstern R; Kupsch A
    J Neurochem; 2003 May; 85(3):601-9. PubMed ID: 12694386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo temporal sequence of rat striatal glutamate, aspartate and dopamine efflux during apomorphine, nomifensine, NMDA and PDC in situ administration.
    Bert L; Parrot S; Robert F; Desvignes C; Denoroy L; Suaud-Chagny MF; Renaud B
    Neuropharmacology; 2002 Oct; 43(5):825-35. PubMed ID: 12384168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.